Blaze Bioscience
Seattle
About Blaze Bioscience
Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. Tumor Paint provides real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors. Blaze Bioscience was founded in 2010.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $55.4M
- Last round: Series Unknown (Feb 2019)
- Website: blazebioscience.com
- Phone: 2062575924
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/blaze-bioscience-25076 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.